Shihezi University School of Medicine - MBBS Fees, Admission & Eligibility 2026

Shihezi University School of Medicine holds NMC approval, WHO listing — the recognitions that directly determine whether your degree is valid for medical practice. For Indian medical students, NMC recognition is non-negotiable — without it, a degree cannot be used for FMGE registration regardless of how highly ranked the university is in China.

Shihezi University School of Medicine's FMGE pass rate of 21.93% (2024) is a more direct measure of training quality than any global ranking. FMGE results reflect how well a university's curriculum and clinical training prepare students for the Indian licensing exam — something rankings based on research output or web visibility cannot capture.

Shihezi University School of Medicine operates as a teaching hospital with 1,200 beds, serving 30,000 students (120 MBBS seats per batch). A 500+ bed teaching hospital provides the case diversity and clinical volume that directly impacts graduate preparedness.

Founded in 1949, Shihezi University School of Medicine is a public institution with 77 years of operation in China. As a public university, it typically benefits from state funding, which supports infrastructure maintenance and faculty retention.

Shihezi University School of Medicine delivers its MBBS program in English. English-medium instruction in China eliminates the language barrier that affects clinical training and FMGE preparation at non-English universities.